Medmix AGMDMXF 61 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review. Among 1,930 Industrial Products companies, Medmix AG ranks worse than 61.09% on this metric.
Medmix AG's yield on cost for the quarter that ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Medmix AG's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 8 years, Medmix AG's highest Yield on Cost was 6.33. The lowest was 1.92. And the median was 4.11.
MDMXF's 5-Year Yield-on-Cost % is not ranked *
in the Industrial Products industry.
Industry Median: 1.8 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Medmix AG (OTCPK:MDMXF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medmix AG 5-Year Yield-on-Cost % Related Terms
MDMXF vs GEV, ETN, PH: 5-Year Yield-on-Cost % Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG 5-Year Yield-on-Cost % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medmix AG's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Medmix AG is calculated as
Medmix AG (MDMXF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medmix AG and its competitors. Over the past decade, Medmix AG's 5-Year Yield-on-Cost % has ranged from 1.92 to 6.33. According to the industry distribution chart, Medmix AG ranks #1179 out of 1930 companies in the Industrial Products industry, placing it in the top 61.1%.
Is Medmix AG's 5-Year Yield-on-Cost % too high?
Medmix AG's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.92 to a high of 6.33. Based on the distribution chart, Medmix AG ranks #1179 out of 1930 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's 5-Year Yield-on-Cost % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1179 out of 1930 companies for 5-Year Yield-on-Cost %. This places Medmix AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.80. Historically, Medmix AG's own 5-Year Yield-on-Cost % has ranged from 1.92 to 6.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Industrial Products company?
The median 5-Year Yield-on-Cost % among Industrial Products companies is 1.80, based on 1,930 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median 5-Year Yield-on-Cost % is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medmix AG (MDMXF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 